Impacts and outcomes of our support
In 2019 we commissioned York Health Economic Consortium ( YHEC ) to evaluate the innovation ’ s cost-effectiveness compared to standard care in the NHS . The following year , funded by the NHS , the Accelerated Access Collaborative ( AAC ), the National Institute for Health Research ( NIHR ) and in partnership with what at the time was the NHS Leeds Clinical Commissioning Group , we supported Healthy . io with the roll-out of the programme in Leeds . Within the first six weeks , nearly 800 patients were contacted , and this figure reached nearly 2,000 in less than a year .
“ From the successes of our initial pilot study , by September 2020 we ’ d moved on to do a more significant roll-out in Leeds . Health Innovation Yorkshire & Humber was instrumental in sourcing the funding from NHSX that helped to make that possible . By April 2021 , again by working in partnership with Health Innovation Yorkshire & Humber and the local health system , we ’ d moved on to a West Yorkshire-wide launch . It grew from city scale to a regional scale . In summer 2021 , we then deployed into the Humber region , so it became something that involved multiple health systems in the Yorkshire and Humber footprint .”
– Jimmy Endicott
Impacts and outcomes of our support
We have continued to work with Healthy . io helping secure funding and supporting with the roll-out of the service across our region . To date , the Minuteful Kidney home testing kit has been offered to over 50,000 eligible patients , of which 51 % have completed a test ( 26,216 ). Out of those , over 11,000 tested abnormal or high abnormal – a high abnormal strongly indicating they have CKD . This means that those patients are being followed up on the appropriate care pathway , allowing early intervention where necessary . Patient satisfaction on the use and recommendation of the service is high , 93 % reported that the test was “ very easy ” or “ easy ” with the oldest patient using it being aged 104 .
Based on the economic modelling that we commissioned YHEC to carry out , it is estimated that 5,119 new cases of CKD have been identified . The economic benefits of the service outlined in the YHEC study shows that across West Yorkshire the estimated net cost savings over the first year were £ 289,652 increasing to £ 20,150,494 by year five . The savings are calculated based on the costs associated with management of End Stage Renal Disease ( ESRD ) and incidents common in later stage CKD .
“ Sometimes the thing that gets in the way of scalability is being able to evidence unquestionably the robustness and success of an innovation , and Health Innovation Yorkshire & Humber helped with that by commissioning two rigorous independent evaluations of our work . They have also supported us in how we present this dataset to the clinical community . That was all made possible through Health Innovation Yorkshire & Humber .”
35 Transforming Lives Through Innovation